Although we are only three months removed from the U.S. Supreme Court’s decision in Bristol-Myers Squibb Co. v. Superior Court of California, 137 S. Ct. 1773 (2017), much ink has already been spilled predicting the demise of so-called “litigation tourism.”

Read the article here.